The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...

Success in AI innovation and adoption is based on a new strategic blueprint, one where innovation is correlated with four key ...

Aima ranked first in the 2025 China Customer Satisfaction Index C-CSI for its industry. Notably, only a few brands saw an ...

This demand is commonly referred to as urgent order processing. In the Zhangzhou area, when enterprises face tight product ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

This important study demonstrates that ocular organoids can generate both retina and lens through a non-canonical, "inside-out" morphogenetic route. The work is solid, with well-designed experiments ...

Here are some of the highlights of the Linux 6.17 release: Specific support for single-core processors has been removed, and ...

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine ...

Corruption in public spending isn’t an abstraction for Filipinos; we see it every time a “completed” project turns out to be a patch of mud or a slab that cracks after the first rain. This year’s ...

BACKGROUND: PYGM (muscle glycogen phosphorylase), the rate-limiting enzyme in glycogenolysis, plays an indispensable role in maintaining cardiac energy metabolism. However, the role of PYGM in the ...